ZA837748B - Celiprolol for the treatment of glaucoma - Google Patents

Celiprolol for the treatment of glaucoma

Info

Publication number
ZA837748B
ZA837748B ZA837748A ZA837748A ZA837748B ZA 837748 B ZA837748 B ZA 837748B ZA 837748 A ZA837748 A ZA 837748A ZA 837748 A ZA837748 A ZA 837748A ZA 837748 B ZA837748 B ZA 837748B
Authority
ZA
South Africa
Prior art keywords
celiprolol
glaucoma
treatment
Prior art date
Application number
ZA837748A
Other languages
English (en)
Inventor
Peter S Wolf
Morris A Kesselman
Original Assignee
Usv Pharma Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Usv Pharma Corp filed Critical Usv Pharma Corp
Publication of ZA837748B publication Critical patent/ZA837748B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/17—Amides, e.g. hydroxamic acids having the group >N—C(O)—N< or >N—C(S)—N<, e.g. urea, thiourea, carmustine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Ophthalmology & Optometry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
ZA837748A 1982-10-27 1983-10-18 Celiprolol for the treatment of glaucoma ZA837748B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/437,072 US4470965A (en) 1982-10-27 1982-10-27 Celiprolol for the treatment of glaucoma

Publications (1)

Publication Number Publication Date
ZA837748B true ZA837748B (en) 1984-06-27

Family

ID=23734943

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA837748A ZA837748B (en) 1982-10-27 1983-10-18 Celiprolol for the treatment of glaucoma

Country Status (16)

Country Link
US (1) US4470965A (de)
EP (1) EP0109561B1 (de)
JP (1) JPS5998016A (de)
AR (1) AR230952A1 (de)
AT (1) ATE33098T1 (de)
AU (1) AU562110B2 (de)
CA (1) CA1220719A (de)
DE (1) DE3376051D1 (de)
DK (1) DK491483A (de)
FI (1) FI833928A (de)
IE (1) IE56177B1 (de)
IL (1) IL70050A (de)
MX (1) MX7289E (de)
NZ (1) NZ206069A (de)
PH (1) PH19559A (de)
ZA (1) ZA837748B (de)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3410380A1 (de) * 1984-03-21 1985-10-10 Lentia GmbH Chem. u. pharm. Erzeugnisse - Industriebedarf, 8000 München S(-)-celiprolol, dessen pharmazeutisch vertraegliche salze, verfahren zu dessen herstellung, verwendung in der therapie und pharmazeutische zubereitungen
IL80298A (en) * 1986-10-14 1993-01-31 Res & Dev Co Ltd Eye drops
DE3636209A1 (de) * 1986-10-24 1988-04-28 Lentia Gmbh Verfahren zur herstellung eines bindemittelfreien tablettierfaehigen celiprololhydrochlorid-granulates
US5055456A (en) * 1989-01-27 1991-10-08 American Cyanamid Co. Anti-alopecia composition
US5075105A (en) * 1989-09-27 1991-12-24 Avetisov Eduard S Composition for treatment of progressive myopia
EP0589020A4 (en) * 1992-03-18 1994-07-06 Coopervision Pharma Verapamil hcl formulation and other ophthalmic solutions with buffer system for ocular administration
EP0639070B2 (de) * 1992-05-06 2010-09-08 Alcon Laboratories, Inc. Anwendung von boral-polyol-komplexen für ophthalmische arzneizusammensetzungen
US5505953A (en) 1992-05-06 1996-04-09 Alcon Laboratories, Inc. Use of borate-polyol complexes in ophthalmic compositions
US5362758A (en) * 1992-09-18 1994-11-08 Pfizer Inc. Ophthalmic piroxicam solution
CA2125060C (en) * 1993-07-02 1999-03-30 Henry P. Dabrowski Ophthalmic solution for artificial tears
TW431888B (en) * 1994-02-03 2001-05-01 Schering Plough Healthcare Nasal spray compositions
US5897858A (en) * 1994-02-03 1999-04-27 Schering-Plough Healthcare Products, Inc. Nasal spray compositions exhibiting increased retention in the nasal cavity
JP3297969B2 (ja) * 1994-12-26 2002-07-02 ライオン株式会社 点眼剤
US5895645A (en) * 1995-01-31 1999-04-20 Bausch & Lomb Incorporated Opthalmic solution for artificial tears
US5800807A (en) * 1997-01-29 1998-09-01 Bausch & Lomb Incorporated Ophthalmic compositions including glycerin and propylene glycol
US5916179A (en) * 1997-04-18 1999-06-29 Sharrock; Nigel System and method for reducing iatrogenic damage to nerves
CA2342797A1 (en) * 1998-09-02 2000-03-09 Allergan Sales, Inc. Preserved cyclodextrin-containing compositions
US20040152664A1 (en) * 1998-09-02 2004-08-05 Allergan, Inc. Prednisolone compositions
JP4255656B2 (ja) * 2001-09-17 2009-04-15 株式会社メニコン 眼科用液剤及びコンタクトレンズ用液剤
JPWO2003029199A1 (ja) * 2001-09-28 2005-01-13 武田薬品工業株式会社 ベンゼン誘導体、その製造法および用途
US20060058388A1 (en) * 2003-01-03 2006-03-16 Bernstein Eric F Methods for treating ocular diseases via introxide and or polyhydroxy acid containing compounds
US6933289B2 (en) 2003-07-01 2005-08-23 Allergan, Inc. Inhibition of irritating side effects associated with use of a topical ophthalmic medication
US20060073172A1 (en) * 2004-10-01 2006-04-06 Schneider L W Stabilized ophthalmic solution for the treatment of glaucoma and lowering intraocular pressure
US20060229219A1 (en) * 2005-04-11 2006-10-12 Advanced Medical Optics, Inc. Borate-polyol mixtures as a buffering system
US20080021068A1 (en) * 2006-07-24 2008-01-24 Akorn, Inc. Aqueous gel formulation and method for inducing topical anesthesia
EP2249871A4 (de) * 2008-03-07 2011-03-16 Sun Pharma Advanced Res Co Ltd Ophthalmische zusammensetzung
TWI544922B (zh) 2011-05-19 2016-08-11 愛爾康研究有限公司 高濃度歐羅派特錠（ｏｌｏｐａｔａｄｉｎｅ）眼用組成物

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4038313A (en) * 1970-01-08 1977-07-26 Ciba-Geigy Corporation Cycloalkylureido phenoxy propanolamines
US4120978A (en) * 1970-01-08 1978-10-17 Ciba-Geigy Corporation Pharmaceutical composition for inhibiting and blocking cardioselective beta-receptors
SE386892B (sv) * 1972-07-06 1976-08-23 Haessle Ab Forfarande for framstellning av oxaminoforeningar
HU170678B (de) * 1973-12-20 1977-08-28
AT334385B (de) * 1973-12-20 1976-01-10 Chemie Linz Ag Verfahren zur herstellung von neuen phenoxypropylaminderivaten und deren salzen
US4178374A (en) * 1974-08-16 1979-12-11 Merck & Co., Inc. Novel pharmaceutical compositions of β-blockers with diuretics

Also Published As

Publication number Publication date
JPS5998016A (ja) 1984-06-06
DK491483D0 (da) 1983-10-26
US4470965A (en) 1984-09-11
AU562110B2 (en) 1987-05-28
EP0109561A1 (de) 1984-05-30
FI833928A0 (fi) 1983-10-27
FI833928A (fi) 1984-04-28
PH19559A (en) 1986-05-21
IL70050A0 (en) 1984-01-31
ATE33098T1 (de) 1988-04-15
DK491483A (da) 1984-04-28
NZ206069A (en) 1987-07-31
IL70050A (en) 1986-11-30
IE56177B1 (en) 1991-05-08
AU2043983A (en) 1984-05-03
MX7289E (es) 1988-04-15
EP0109561B1 (de) 1988-03-23
AR230952A1 (es) 1984-08-31
DE3376051D1 (en) 1988-04-28
CA1220719A (en) 1987-04-21

Similar Documents

Publication Publication Date Title
DE3376051D1 (en) Celiprolol for the treatment of glaucoma
DE3364150D1 (en) Benzothiazolesulfonamide derivatives for the topical treatment of elevated intraocular pressure
PT76830A (en) Process for the preparation of 1h-indole-methanesulphonamides
DE3368047D1 (en) Process for the preparation of p-nitrosodiphenylamine
CY1470A (en) Process for the preparation of phenylalkylaminoethylsalicylamide
GB8326185D0 (en) Treatment of aluminium
DE3368627D1 (en) Process for the preparation of 8,12-epoxy-13,14,15,16-tetranor labdane
GB8402515D0 (en) Universal water treatment
ZA836193B (en) Process for the preparation of n-allyl-o-alkyl thioncarbamates
JPS57181011A (en) Nadrol composition for glaucoma treatment
PT76175A (en) Process for the preparation of benzothienyl-dialkylallylamines
GB2124488B (en) Agent for the treatment of wounds
DE3362429D1 (en) Process for the preparation of thiadiazoloxyacetamides
DE3372479D1 (en) Process for the preparation of 4-chloro-2-nitrobenzonitrile
DE3367912D1 (en) Process for the preparation of n-allyl-o-alkyl-thioncarbamates
DE3361356D1 (en) Process for the preparation of 3-acylaminoanilines
DE3360384D1 (en) Process for the preparation of 1-hydroxyketones
DE3269747D1 (en) Process for the preparation of carbamates
DE3365382D1 (en) Process for the preparation of 2-chlorobenzoxazols
JPS5651413A (en) Glaucoma treatment
DE3268043D1 (en) Process for the preparation of stilbene-4,4&#39;-dialdehyde
ZA842958B (en) Benzothiazolesulfonamide for the topical treatment of elevated intraocular pressure
GB2120245B (en) Process for the preparation of 3-hydroxy-benzo-diazepinones
DE3369844D1 (en) Process for the preparation of 2-imidazolines
DE3365483D1 (en) Process for the preparation of 2-alkylthiomethyl-4-hydroxy-pyrimidines